tratamiento de semaglutide Pensando en Ozempic o Wegovy para perder peso? Los Centros Toxicología recomiendan precaución Semaglutida: un pilar terapéutico en
Description
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, but concerns about tirzepatide and thyroid nodules have emerged from animal studies showing thyroid C-cell tumors in rodents
Both partners should be encouraged to optimize overall health, maintain achieved weight loss through lifestyle measures, and work closely with their healthcare teamincluding reproductive specialists when indicatedto ensure the safest approach to family planning while managing chronic metabolic conditions
In patients with heart failure with preserved ejection fraction, semaglutide treatment led to greater improvements in exercise function and weight loss as compared to a placebo
Joint pain complaints also appear in post-marketing data for both medications
Take the first step to a healthier and happier version of yourself
Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al
